References
- Svensson C, Pipkorn U, Alkner U, Baumgarten CR, Persson CGA. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 1992; 22: 411–6.
- Greiff L, Akerlund A, Andersson M, Svensson C, Alkner U, Persson CGA. Day-night differences in mucosal plasma proteins in common cold. Acta Otolar-yngol (Stockh) 1996; 116: 85–90.
- Brofeldt S, Mygind N, Sorensen CH, Readman AS, Marriot C. Biochemical analysis of nasal secretions induced by methacholine, histamine, and allergen provocations. Am Rev Respir Dis 1986; 133: 1138–42.
- Raphael GD, Druce HM, Baraniuk IN, Kaliner MA. Pathophysiology of rhinitis 1. Assessment of the sources of protein in methacholine-induced nasal secre-tions. Am Rev Respir Dis 1988; 138: 413–20.
- Bende M, Barrow I, Heptonstall J, et al. Changes in human nasal mucosa during experimental coronavirus common colds. Acta Otolaryngol (Stockh) 1989; 107: 262–9.
- Weeks I, Beheshti I, McCapra F, Campbell AK, Woodhead JS. Acridinium esters as high specific activ-ity labels in immunoassay. Clin Chem 1983; 29: 1474–9.
- Horton JK, Davies M, Woodhead JS, Weeks I. A rapid and sensitive method for estimating low concen-trations of albumin in human urine. Clin Chim Acta 1989; 186: 45–52.
- Katoh M, Chishima S, Kiuchi N, Ikeo T, Sasaki Y. A new method for the assay of exposed platelet fibrinogen receptor using a chemiluminescent label. Thromb Haem 1995; 74: 1546–50.
- Campbell AK. A natural history of chemiluminescence. In: Chemiluminescence: principles and applications in biology and medicine. Chichester: Ellis Horwood Ltd, 1988.
- Weeks I, Sturgess M, Brown RC, Woodhead JS. Chemiluminescence: immunoassays using acridinium esters. In: Deluda M, McElroy J, editors. Methods in enzymology, New York: Academic Press, 1986, vol 133 p. 366–87.
- Housley DG, Eccles R, Richards RJ. Gender difference in the concentration of the antioxidant uric acid in human nasal lavage. Acta Otolaryngol (Stockh) 1996; 116: 751–4.
- Browning ST, Housley D, Rogers R, Eccles R. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa. Acta Otolaryngol (Stockh) 1997; 117: 851–5.
- Ekins R. Immunoassay design and optimisation. In: Price CP, Newman DJ, eds. Principles and practice of immunoassay. Park Avenue South, New York: Stock-ton Press, 1991: 97–153.
- Kaliner MA. Human nasal respiratory secretions and host defence. Am Rev Respir Dis 1991; 144: S52–6.
- Widdicombe JG, Wells UM. Airway secretions. In: Proctor DF, Andersen IB, eds. The nose: upper airway physiology and the atmospheric environment. Amster-dam: Elsevier Biomedical Press, 1982: 215–37.
- Raphael GD, Meredith SD, Baraniuk IN, Druce HM, Banks SM, Kaliner MA. The pathophysiology of rhini-tis II. Assessment of the sources of protein in his-tamine-induced nasal secretions. Am Rev Respir Dis 1989; 139: 791–800.